Texas Screwworm Scare Sparks Surge in Zoetis and Elanco Animal Health Stocks

The detection of the New World screwworm, a parasitic fly that infests livestock, in Texas has sent ripples through the financial markets, causing shares of key animal health companies to climb. Zoetis Inc. and Elanco Animal Health Inc. saw significant stock price increases during Thursday's trading session, accompanied by a notable surge in options market activity, particularly with a bullish sentiment.

Zoetis shares experienced a jump of nearly 4%, while Elanco's stock rose by 2% in midday trading, reflecting investor optimism spurred by the news. The uptick in trading volume suggests traders are anticipating increased demand for products and services that combat or manage the screwworm infestation.

Zoetis, in particular, has seen a significant boost in trading activity. The company's injectable product, which received conditional approval from the FDA last year for treating and preventing screwworm reinfestation, has become a focal point. The FDA's emergency use authorization for the over-the-counter drug further bolsters its market position. Options volume for Zoetis surged to nearly 20 times its daily average, with a substantial number of call options traded, indicating strong bullish expectations. One notable trade involved the purchase of nearly $700,000 worth of 80-calls expiring July 17, suggesting a belief that the stock could climb an additional 5% by mid-July.

The spread of screwworm is a growing concern, with reports indicating its presence in tens of thousands of animals in Mexico. Experts warn that if cases become more widespread, especially in wildlife, controlling the infestation could become significantly more challenging. Despite these concerns, cattle futures have remained relatively stable, continuing a multiyear rally. However, a widespread outbreak could potentially strain beef supplies.

"The No. 1 preferred commodity in the U.S. is beef – Americans love their fast food so if you have any issue with the beef supply chain, it'll have some market volatility," said Ben Rand, a Nebraska-based broker for Blue Line Futures. "We just had a conditional use drug approved; U.S. producers can handle it." This suggests that while the screwworm poses a threat, the industry may be equipped to manage its impact, particularly with the availability of approved treatments.